Spergel; Steven H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Spergel; Steven H..The latest application filed is for "triazolopyridinyl compounds as kinase inhibitors".

Company Profile

10.35.35

Spergel; Steven H. - Warrington PA
- Warrington PA US
Spergel; Steven H. - Bensalem PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aminoimidazopyridazines as kinase inhibitors Grant 11,440,913 - Mertzman , et al. September 13, 2	2022-09-13
Triazolopyridinyl Compounds As Kinase Inhibitors App 20220119388 - Luo; Guanglin ; et al.	2022-04-21
Substituted imidazo[1,2-b]pyridazines as interleukin-23 and interferon-.alpha. modulators Grant 11,299,494 - Weinstein , et al. April 12, 2	2022-04-12
Imidazopyridazine Compounds App 20210323966 - WEINSTEIN; David S. ; et al.	2021-10-21
Aminotriazolopyridines as kinase inhibitors Grant 10,913,738 - Guo , et al. February 9, 2	2021-02-09
Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or INF alpha responses Grant 10,836,770 - Spergel , et al. November 17, 2	2020-11-17
Aminoimidazopyridazines As Kinase Inhibitors App 20200277296 - Mertzman; Michael E. ; et al.	2020-09-03
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Grant RE47,929 - Moslin , et al.	2020-04-07
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20200071315 - Moslin; Ryan M. ; et al.	2020-03-05
Aminotriazolopyridines As Kinase Inhibitors App 20190389859 - Guo; Junqing ; et al.	2019-12-26
Imidazopyridazine Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20190225620 - Spergel; Steven H. ; et al.	2019-07-25
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20180265504 - Moslin; Ryan M. ; et al.	2018-09-20
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Grant 10,000,480 - Moslin , et al. June 19, 2	2018-06-19
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20170022192 - Moslin; Ryan M. ; et al.	2017-01-26
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN.alpha. responses Grant 9,505,748 - Moslin , et al. November 29, 2	2016-11-29
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 9,221,826 - Wrobleski , et al. December 29, 2	2015-12-29
Amide-substituted Heterocyclic Compounds Useful As Modulators Of Il-12, Il-23 And/or Ifn Alpha Responses App 20150299183 - Moslin; Ryan M. ; et al.	2015-10-22
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 8,987,268 - Wrobleski , et al. March 24, 2	2015-03-24
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 8,921,368 - Wrobleski , et al. December 30, 2	2014-12-30
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Grant 08921368 -	2014-12-30
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140011795 - Wrobleski; Stephen T. ; et al.	2014-01-09
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140011800 - Wrobleski; Stephen T. ; et al.	2014-01-09
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases App 20140005146 - Wrobleski; Stephen T. ; et al.	2014-01-02
Substituted heterocyclic compounds Grant 8,404,672 - Pitts , et al. March 26, 2	2013-03-26
Substituted isoxazole compounds Grant 8,354,398 - Watterson , et al. January 15, 2	2013-01-15
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same Grant 8,268,855 - Pitts , et al. September 18, 2	2012-09-18
Substituted Heterocyclic Compounds App 20120022041 - Pitts; William J. ; et al.	2012-01-26
Substituted Isoxazole Compounds App 20110300165 - Watterson; Scott Hunter ; et al.	2011-12-08
1,6-dihydro-1,3,5,6-tetraaza-as-indacene Based Tricyclic Compounds And Pharmaceutical Compositions Comprising Same App 20100210629 - Pitts; William J. ; et al.	2010-08-19
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same Grant 7,737,279 - Pitts , et al. June 15, 2	2010-06-15
1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same Grant 7,683,171 - Pitts , et al. March 23, 2	2010-03-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,655,689 - Salvati , et al. February 2, 2	2010-02-02
8H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same Grant 7,557,211 - Das , et al. July 7, 2	2009-07-07
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,517,904 - Salvati , et al. April 14, 2	2009-04-14
Imidazo-fused oxazolo [4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same Grant 7,456,194 - Dyckman , et al. November 25, 2	2008-11-25
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 7,241,781 - Barrish , et al. July 10, 2	2007-07-10
Imidazo-fused oxazolo[4,5-.beta.]pyridine and imidazo-fused thiazolo[4,5-.beta.]pyridine based tricyclic compounds and pharmaceutical compositions comprising same Grant 7,176,214 - Pitts , et al. February 13, 2	2007-02-13
1,6-Dihydro-1,3,5,6-Tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same App 20060270654 - Pitts; William J. ; et al.	2006-11-30
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function Grant 7,141,578 - Salvati , et al. November 28, 2	2006-11-28
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060264459 - Salvati; Mark E. ; et al.	2006-11-23
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20060223832 - Salvati; Mark E. ; et al.	2006-10-05
Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same App 20060217412 - Pitts; William J. ; et al.	2006-09-28
1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same App 20060178393 - Pitts; William J. ; et al.	2006-08-10
8H-imidazo[4,5-D]thiazolo[4,5-B]pyridine based tricyclic compounds and pharmaceutical compositions comprising same App 20060128741 - Das; Jagabandhu ; et al.	2006-06-15
Imidazo-fused oxazolo[4,5-b]pyridine and imidazo-fused thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same App 20060106051 - Dyckman; Alaric ; et al.	2006-05-18
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 7,037,926 - Barrish , et al. May 2, 2	2006-05-02
Thiazolyl inhibitors of Tec family tyrosine kinases App 20060030598 - Barrish; Joel C. ; et al.	2006-02-09
Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050272799 - Salvati, Mark E. ; et al.	2005-12-08
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 6,958,336 - Barrish , et al. October 25, 2	2005-10-25
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 6,956,045 - Barrish , et al. October 18, 2	2005-10-18
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 6,953,795 - Barrish , et al. October 11, 2	2005-10-11
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20050192253 - Salvati, Mark E. ; et al.	2005-09-01
Imidazo-fused oxazolo[4,5-beta]pyridine and imidazo-fused thiazolo[4,5-beta]pyridine based tricyclic compounds and pharmaceutical compositions comprising same App 20050101626 - Pitts, William J. ; et al.	2005-05-12
Thiazolyl inhibitors of Tec family tyrosine kinases App 20040110752 - Barrish, Joel C. ; et al.	2004-06-10
Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function App 20040077605 - Salvati, Mark E. ; et al.	2004-04-22
Thiazolyl inhibitors of Tec family tyrosine kinases App 20040077695 - Barrish, Jo I C. ; et al.	2004-04-22
Thiazolyl inhibitors of Tec family tyrosine kinases App 20040067989 - Barrish, Joel C. ; et al.	2004-04-08
Thiazolyl inhibitors of Tec family tyrosine kinases App 20040067990 - Barrish, Joel C. ; et al.	2004-04-08
Thiazolyl inhibitors of Tec family tyrosine kinases Grant 6,706,717 - Barrish , et al. March 16, 2	2004-03-16
Imidazoquinoxaline protein tyrosine kinase inhibitors Grant 6,635,626 - Barrish , et al. October 21, 2	2003-10-21
Thiazolyl inhibitors of Tec family tyrosine kinases App 20030069238 - Barrish, Joel C. ; et al.	2003-04-10
Substituted biphenyl isoxazole sulfonamides Grant 5,846,990 - Murugesan , et al. December 8, 1	1998-12-08
Tetrahydroethanonaphthaleneamine derivatives Grant 5,202,486 - Barrish , et al. April 13, 1	1993-04-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.